Detail of the clinical trial
| Title of the trial | A Phase II Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia |
|---|---|
| EudraCT number | 2015-000479-28 |
| Protocol number | LTS13932 |
| Sponsor | Genzyme Corporation, 500 Kendall Street, 02142 Cambridge, MA, United States of America |
| Indications | Hemato-oncology |
| Diagnosis | acute myeloid leukemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2015 |
| Date of approval by Institute (SÚKL) | 3.8.2015 |
| Date of approval by EC | 17.8.2015 |
| Date of initiation CT in ČR | |
| Date of ending CT in ČR | |
| Notice | |
| Sites |
Fakultní nemocnice Ostrava, Klinika hematoonkologie, 17. listopadu 1790, 708 52 Ostrava Fakultní nemocnice Hradec Králové, IV. interní hematologická klinika, Sokolská 581, 500 05 Hradec Králové |
cz